Product Information
ACETAMINOPHEN 325 MG GELCAP is a generic product labeled by AmerisourceBergen, priced at $0.0250 per EA under NDC 46122043078. Its NADAC has been published 409 times since Aug 29, 2018.
Strength
325 mg/1
Manufacturer
AmerisourceBergenNDC
46122043078
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
7/24/2015
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG GELCAP has been published 409 times since Aug 29, 2018, and over the history we have for it it has risen 66.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0250 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0135 (Dec 19, 2018) |
| 52-week high | $0.0267 |
| 52-week low | $0.0247 |
| Median price | $0.0232 |
| Average price | $0.0219 |
| Largest weekly change | +55.0% (Jan 20, 2021) |
| Weeks tracked | 409 |
| Tracking since | Aug 29, 2018 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG GELCAP?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG GELCAP, manufactured by AmerisourceBergen, is $0.0250 per EA (NDC 46122043078), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN 325 MG GELCAP changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG GELCAP has risen 66.6%. It has been tracked across 409 weekly CMS publications since Aug 29, 2018.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG GELCAP?
Since Aug 29, 2018, the NADAC for ACETAMINOPHEN 325 MG GELCAP has ranged from a low of $0.0135 (Dec 19, 2018) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0232 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG GELCAP?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 7% below ACETAMINOPHEN 325 MG GELCAP.
Who manufactures ACETAMINOPHEN 325 MG GELCAP?
ACETAMINOPHEN 325 MG GELCAP (NDC 46122043078) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.
Related Drugs
Same classification